Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Maria Teresa Pirro"'
Autor:
Francesco Errico, Mario De Felice, Maria Teresa Pirro, Antimo D'Aniello, Roberto Di Lauro, Andrea Affuso, Patrizia Spinelli
Publikováno v:
Gene. 374:50-57
Free D-aspartic acid and NMDA are present in the mammalian central nervous system and endocrine glands at significant concentrations, but their physiological role is still matter of debate. The only enzyme known to metabolize in vitro selectively the
Autor:
Daniela Terracciano, Maria Teresa Pirro, Claudio Arra, Antonio Riccio, Roberto Di Lauro, Daniela Spano, Annamaria Rosica, Vincenzo Macchia, Juan Bernal, Andrea Affuso, Pratibha Mithbaokar, Patrizia Campolongo, Igor Branchi, Enrico Alleva
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
9 pages, 10 figures.-- et al.
The development and the function of central nervous system depend on thyroid hormones. In humans, the lack of thyroid hormones causes cretinism, a syndrome of severe mental deficiency. It is assumed that thyroid hor
The development and the function of central nervous system depend on thyroid hormones. In humans, the lack of thyroid hormones causes cretinism, a syndrome of severe mental deficiency. It is assumed that thyroid hor
Publikováno v:
Molecular and Cellular Biology. 20:2783-2793
Expression of oncogenic Ras in thyroid cells results in loss of expression of several thyroid-specific genes and inactivation of TTF-1, a homeodomain-containing transcription factor required for normal development of the thyroid gland. In an effort t
Autor:
Massimo Torlontano, L. D'Aloiso, V. De Filippis, L Scarnecchia, A. Di Cerbo, Vittorio Tassi, Maria Teresa Pirro, R. Di Paola, Antonio Liuzzi, Matteo Zingrillo
Publikováno v:
Journal of Molecular Endocrinology. 15:267-272
Autoimmune thyroid diseases (AITDs) are clustered in families, but the nature of this clustering is still poorly understood. One possible approach to the identification of genetic factors interacting with the AITDs is the study of the association bet
Autor:
Maria Rosaria Ghiggi, G. Oppizzi, Vittorio Tassi, Maria Teresa Pirro, Iacopo Chiodini, Matteo Zingrillo, Massimo Barberis, Antonio Liuzzi
Publikováno v:
Metabolism. 45:80-82
The term "nonfunctioning" pituitary adenomas (NFPA) implies heterogeneity, since it relies on a clinical definition that is mainly related to tumor mass. The first complaint is often of impaired visual function, and despite the secretion of gonadotro
The transcription factor thyroid transcription factor-1 (TTF-1) is a homeodomain-containing protein that belongs to the NK2 family of genes involved in organogenesis. TTF-1 is required for normal development of the forebrain, lung, and thyroid. In a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b5fde4584c94dc9910a75aeaee97015
http://hdl.handle.net/11588/573149
http://hdl.handle.net/11588/573149
Autor:
Vito De Ftlippis, Maria Teresa Pirro, Vittorio Tassi, Antonio Liuzzi, Alfredo Di Cerbo, Alfredo Scillitani
Publikováno v:
Thyroid : official journal of the American Thyroid Association. 5(6)
Autoimmune thyroid diseases (AITD) cluster in families, although the nature of this phenomenon is still poorly understood. One possible approach to the identification of genetic factors contributing to the pathogenesis of AITD is the study of associa
Autor:
Francesco Zaja, Marta Lisa Battista, Maria Teresa Pirrotta, Salvatore Palmieri, Michela Montagna, Nicola Vianelli, Luciana Marin, Margherita Cavallin, Monica Bocchia, Marzia Defina, Micaela Ippoliti, Felicetto Ferrara, Francesca Patriarca, Maria Antonietta Avanzini, Mario Regazzi, Michele Baccarani, Miriam Isola, Franca Soldano, Renato Fanin
Publikováno v:
Haematologica, Vol 93, Iss 6 (2008)
Rituximab 375 mg/m2 weekly for four weeks has significant activity in patients with immune thrombocytopenia. We evaluated the activity of lower dose rituximab (100 mg iv weekly for 4 weeks) in 28 adults with idiopathic thrombocytopenic purpura. Overa
Externí odkaz:
https://doaj.org/article/8afb057421c044ada74cb2516caee0c1
Autor:
Pier Paolo Piccaluga, Michele Malagola, Michela Rondoni, Mario Arpinati, Stefania Paolini, Anna Candoni, Renato Fanin, Emanuela Messa, Maria Teresa Pirrotta, Francesco Lauria, Giuseppe Visani, Daniele Alberti, Francesca Rancati, Vincenza Vinaccia, Domenico Russo, Giuseppe Saglio, Michele Baccarani, Giovanni Martinelli
Publikováno v:
Haematologica, Vol 92, Iss 12 (2007)
We evaluated safety and efficacy of imatinib (600 mg) in 36 c-KIT+ acute myeloid leukemia patients not amenable to receive conventional chemotherapy. No patient achieved complete remission. One patient obtained a hematologic improvement (platelet inc
Externí odkaz:
https://doaj.org/article/1b59a6321b3d4ea3b037843e694241c3